SANXING(SH:601567) Sou Hu Cai Jing·2025-07-18 10:40Group 1 - The core viewpoint of the articles highlights Samsung Medical's current market performance, including a closing price of 21.5 yuan, a decline of 2.93%, and a rolling PE ratio of 12.72 times, with a total market capitalization of 30.337 billion yuan [1][2] - The average PE ratio for the electric grid equipment industry is 37.78 times, with a median of 39.13 times, positioning Samsung Medical at the 35th rank within the industry [1][2] - As of the first quarter of 2025, 14 institutions hold shares in Samsung Medical, with a total of 42.8023 million shares valued at 960 million yuan [1] Group 2 - For the first quarter of 2025, Samsung Medical reported an operating income of 3.631 billion yuan, representing a year-on-year increase of 20.03%, and a net profit of 489 million yuan, reflecting a year-on-year growth of 34.33%, with a sales gross margin of 28.90% [2] - The company's PE (TTM) is 12.72, while the industry average is 37.78, indicating a significant undervaluation compared to peers [2] - Samsung Medical's main business segments include smart power distribution, medical services, and various products such as smart meters, high-end gateway meters, and energy storage systems [1]